JPH0452249B2 - - Google Patents
Info
- Publication number
- JPH0452249B2 JPH0452249B2 JP59043829A JP4382984A JPH0452249B2 JP H0452249 B2 JPH0452249 B2 JP H0452249B2 JP 59043829 A JP59043829 A JP 59043829A JP 4382984 A JP4382984 A JP 4382984A JP H0452249 B2 JPH0452249 B2 JP H0452249B2
- Authority
- JP
- Japan
- Prior art keywords
- streptococcus
- lactobacillus
- bacteria
- faecium
- caries
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
本発明は抗う蝕剤、口腔用組成物及び抗う蝕性
飲食品等に関する。
主たるう蝕原因菌であるストレプトコツカス・
ミユータンス(Streptococcus mutans)に対す
る抗菌性物質としては各種バクテリオリシンを始
めとして幾つかが既に提案されているが、例えば
腸内細菌に対する影響等の副作用につき実質的に
未解明であり、日常的服用に於いて必らずしも安
全であるとはなし難いものであるためこれらは未
だ実用に供せられていない。
上記に鑑み本発明者らは鋭意研究の結果、健常
人腸内細菌由来の乳酸菌々体乃至その水抽出物が
S・ミユータンスに対し強い抗菌活性を有するこ
と及びこれら乳酸菌々体乃至水抽出物は腸内細菌
に対する影響も含めて経口投与では実質的に全然
無毒性であることを知見し、本発明に到達したも
のである。
以下、本発明に於いて使用され得る微生物の種
類と菌学的性質、抗う蝕剤の調製、抗菌活性及び
仕様態様等につき詳細に分説する。
微生物
ストレプトコツカス属又はラクトバチルス属に
属する各種微生物が使用され得、就中、ストレプ
トコツカス・フエシウム(Streptococcus
faecium)、ストレプトコツカス・イクイナス
(Streptococcus equinus)、ラクトバチルス・フ
アーメンタム(Lactobacillus fermentum)、ラ
クトバチルス・サリバリウス(Lactobacillus
salivarius)等を好適なものとして例示し得る。
ここで本発明に於いて特に有用な具体的菌株例を
微工研受託番号と共に表示すれば下記第1表の通
りである。
The present invention relates to an anti-caries agent, an oral composition, an anti-caries food and drink, and the like. Streptococcus, the main caries-causing bacterium.
Several antibacterial substances against Streptococcus mutans, including various bacteriolisins, have already been proposed, but their side effects, such as their effects on intestinal bacteria, are virtually unknown, and they cannot be used on a daily basis. However, these materials have not yet been put to practical use because they cannot be guaranteed to be safe. In view of the above, the present inventors conducted extensive research and found that lactic acid bacteria cells derived from healthy human intestinal bacteria or their water extracts have strong antibacterial activity against S. muutans, and that these lactic acid bacteria cells or water extracts are The present invention was achieved based on the finding that oral administration is virtually non-toxic, including the effects on intestinal bacteria. Hereinafter, the types and mycological properties of microorganisms that can be used in the present invention, the preparation of the anti-caries agent, its antibacterial activity, specifications, etc. will be explained in detail. Microorganisms Various microorganisms belonging to the genus Streptococcus or Lactobacillus can be used, especially Streptococcus faecium (Streptococcus faecium).
faecium), Streptococcus equinus, Lactobacillus fermentum, Lactobacillus salivarius
salivarius) etc. can be exemplified as suitable examples.
Here, specific examples of particularly useful bacterial strains in the present invention are shown in Table 1 below, together with the Microtech Institute accession number.
【表】
上記各菌株のスクリーニング方法、菌学的性質
につき要約して示せば次の通りである。
1 スクリーニング方法
Watanabe,T.,et al.,Studies on
streptococci.I.Distribution of fecal
streptococci in man.Microbiol.Immunol.25
257−269(1981)に記載の方法に準ずる。
すなわち、上記文献に記載の通り、健康人のフ
イーシーズをKMN agar 及びLBS agarに塗
沫、好気的条件下で37℃、48〜72時間培養し、生
成コロニーをカウント、無作為にひろい、コロニ
ー形、カタラーゼ陰性、グラム染色陽性球菌及び
桿菌を分離し、生理的、生化学的性状を検査して
分類同定した。
2 分離乳酸菌の同定
ストレプトコツカス属細菌の選択倍地KMN寒
天倍地、ラクトバチルス属細菌の選択倍地LBS
寒天倍地(第2表参照)上のコロニーの形状、グ
ラム染色性、形態、生理生化学的性状により下記
文献1〜5を参照して同定した。[Table] The screening method and mycological properties of each of the above strains are summarized as follows. 1 Screening method Watanabe, T., et al., Studies on
streptococci.I.Distribution of fecal
streptococci in man.Microbiol.Immunol.25
257-269 (1981). That is, as described in the above-mentioned literature, the seeds of a healthy person were smeared onto KMN agar and LBS agar, cultured under aerobic conditions at 37°C for 48 to 72 hours, and the resulting colonies were counted and randomly picked. Catalase-negative, Gram-stain-positive cocci and bacilli were isolated and classified and identified by examining their physiological and biochemical properties. 2 Identification of isolated lactic acid bacteria Selective medium for Streptococcus bacteria: KMN agar medium; selective medium for Lactobacillus bacteria: LBS
Identification was performed based on the shape, Gram stainability, morphology, and physiological and biochemical properties of colonies on agar medium (see Table 2) with reference to the following documents 1 to 5.
【表】
別滅菌後、合し平板とする
[Table] After separate sterilization, combine them into flat plates.
【表】
同定の根拠とした菌学的性質を要約して示せば
下記第3乃至7表の通りである。[Table] The mycological properties on which the identification was based are summarized in Tables 3 to 7 below.
【表】【table】
【表】【table】
【表】【table】
【表】【table】
【表】【table】
【表】
+;陽性 −;陰性
[Table] +; Positive -; Negative
【表】【table】
Claims (1)
トコツカス・イクイナス、ラクトバチルス・フア
ーメンタム、及びラクトバチルス・サリバリウス
の菌体及び/又は水抽出物を有効成分として含有
することを特徴とする抗う蝕剤。1. An anti-caries agent characterized by containing bacterial cells and/or water extracts of Streptococcus faecium, Streptococcus equinus, Lactobacillus fermentum, and Lactobacillus salivarius as an active ingredient.
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59043829A JPS60190707A (en) | 1984-03-09 | 1984-03-09 | Cariostatic agent |
| CA000475879A CA1262442A (en) | 1984-03-09 | 1985-03-06 | Anticariogenic or antiperiodontitic agent |
| EP85301529A EP0154549B1 (en) | 1984-03-09 | 1985-03-06 | Anticariogenic or antiperiodontitic agent |
| DE8585301529T DE3581091D1 (en) | 1984-03-09 | 1985-03-06 | ANTI-CARIES OR ANTI-PERIODONTITIS AGENT. |
| US06/709,668 US4746512A (en) | 1984-03-09 | 1985-03-08 | Anticariogenic or antiperiodontitic agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59043829A JPS60190707A (en) | 1984-03-09 | 1984-03-09 | Cariostatic agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60190707A JPS60190707A (en) | 1985-09-28 |
| JPH0452249B2 true JPH0452249B2 (en) | 1992-08-21 |
Family
ID=12674642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59043829A Granted JPS60190707A (en) | 1984-03-09 | 1984-03-09 | Cariostatic agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60190707A (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5352586A (en) * | 1987-05-01 | 1994-10-04 | Biogaia Ab | Method of determining the presence of an antibiotic produced by Lactobacillus reuteri |
| US5413960A (en) * | 1987-05-01 | 1995-05-09 | Biogaia Ab | Antibiotic reuterin |
| US4828849A (en) * | 1988-01-14 | 1989-05-09 | Warner-Lambert Company | Surfactant inhibition of dental plaque |
| US5534253A (en) * | 1995-06-07 | 1996-07-09 | Biogaia Ab | Method of treating enteropathogenic bacterial infections in poultry |
| EP1091765A4 (en) * | 1998-06-30 | 2001-10-24 | Invitrogen Corp | METHOD FOR REDUCING RANDOMOUS TOXINS AND CELL CULTURE REAGENTS PRODUCED BY THEM |
| IT1306716B1 (en) * | 1999-06-21 | 2001-10-02 | Mendes S U R L | ASSOCIATION OF LACTIC BACTERIA AND ITS USE FOR THE PREVENTION AND / OR THERAPEUTIC TREATMENT OF INFECTIONS AND INFLAMMATORY STATES. |
| JP4528472B2 (en) * | 2001-11-29 | 2010-08-18 | ビオフェルミン製薬株式会社 | Preventive or therapeutic agent for periodontal disease |
| JP2006219441A (en) * | 2005-02-14 | 2006-08-24 | Kuraray Family Seihin Kk | Prophylactic agent for dental caries or periodontal disease |
| US12485459B2 (en) | 2021-07-08 | 2025-12-02 | Industrial Vacuum Transfer Services Usa, Llc | Systems, assemblies, and methods for pyrophoric material extraction |
| US12246932B2 (en) | 2021-07-08 | 2025-03-11 | Industrial Vacuum Transfer Services Usa, Llc | Methods for loading and extracting product in elevated tower |
| US12137864B2 (en) | 2021-07-08 | 2024-11-12 | Industrial Vacuum Transfer Services Usa, Llc | Assemblies and methods for material extraction |
| US12098068B2 (en) | 2021-07-08 | 2024-09-24 | Industrial Vacuum Transfer Services Usa, Llc | Systems, methods, and devices for industrial tower waste extraction |
| US12193627B2 (en) | 2021-07-08 | 2025-01-14 | Industrial Vacuum Transfer Services Usa, Llc | High volume industrial vacuum assemblies and methods |
| US12103791B2 (en) | 2021-07-08 | 2024-10-01 | Industrial Vacuum Transfer Services Usa, Llc | Assemblies and methods for material extraction from retention collections |
| US12091264B2 (en) | 2021-07-08 | 2024-09-17 | Industrial Vacuum Transfer Services Usa, Llc | Assemblies, apparatuses, systems, and methods for material extraction and conveyance |
| US12510077B2 (en) | 2021-07-08 | 2025-12-30 | Industrial Vacuum Transfer Services Usa, Llc | Air compressor having vacuum and associated methods for loading and extracting materials |
| WO2024117190A1 (en) | 2022-11-30 | 2024-06-06 | アサヒグループホールディングス株式会社 | Composition for maintaining health of intraoral environment or gums |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4962624A (en) * | 1972-10-17 | 1974-06-18 | ||
| JPS5850962B2 (en) * | 1975-10-02 | 1983-11-14 | ライオン株式会社 | Oral hygiene composition |
| ZA794413B (en) * | 1978-09-01 | 1980-08-27 | Us Government | Protection against dental caries |
| US4287173A (en) * | 1979-09-24 | 1981-09-01 | Merck & Co., Inc. | Vaccine for dental caries |
| JPS59220191A (en) * | 1983-04-07 | 1984-12-11 | Kitasato Inst:The | Noncariogenic composition and drink |
| JPS6064930A (en) * | 1983-09-20 | 1985-04-13 | Kitasato Inst:The | Vaccine for carious teeth |
| JPS60243024A (en) * | 1983-12-29 | 1985-12-03 | Kitasato Inst:The | Vaccine for preventing infections disease caused by streptococcus sanguis, and antigen and antibody for diagnosis |
-
1984
- 1984-03-09 JP JP59043829A patent/JPS60190707A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60190707A (en) | 1985-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0154549B1 (en) | Anticariogenic or antiperiodontitic agent | |
| CA1246445A (en) | Intestinal microflora-improving agent | |
| US5709857A (en) | Lactobacillus strains of human origin, their compositons and uses thereof | |
| Meurman et al. | Recovery of Lactobacillus strain GG (ATCC 53103) from saliva of healthy volunteers after consumption of yoghurt prepared with the bacterium | |
| US9192177B2 (en) | Feline probiotic Lactobacilli | |
| US9404162B2 (en) | Feline probiotic bifidobacteria and methods | |
| JPH0452249B2 (en) | ||
| DE60003515T2 (en) | BEVERAGES AND FOODS SUITED TO ELIMINATE HELICOBACTER PYLORI | |
| SK17172001A3 (en) | The lactic acid bacteria composition and its use for the prevention and / or treatment of infections and inflammatory conditions | |
| Ishihara et al. | Growth inhibition of Streptococcus mutans by cellular extracts of human intestinal lactic acid bacteria | |
| JPS62145026A (en) | Anticarcinogenic agent | |
| KR20200032672A (en) | NOVEL STRAIN OF Lactobacillus plantarum AND COMPOSITION FOR PREVENTING OR TREATING OF INFLAMMATORY DISEASE USING THE SAME | |
| Murphy | In vivo assessment of potential probiotic Lactobacillus salivarius strains: evaluation of their establishment, persistence, and localisation in the murine gastrointestinal tract | |
| JP2006508943A (en) | Methods for inhibiting yeast growth | |
| CN116024128A (en) | Streptococcus thermophilus strain P0012, and probiotic composition for oral health care prepared from same and application of probiotic composition | |
| JP4308481B2 (en) | Antiallergic agent | |
| CN111642746A (en) | A kind of food, oral cleaning and pharmaceutical composition for inhibiting oral pathogenic bacteria | |
| CN107530382A (en) | Caries preventive agent and preventing decayed tooth composition | |
| RU2215027C2 (en) | Strain of bacterium lactobacillus rhamnosus 12l for preparing biologically active supplement regulating intestine microflora in children of early age | |
| Ndeokwelu et al. | Probiotic Profiling of Selected Yogurt Drinks in Benin City, Edo-State, Nigeria | |
| Barjatya et al. | Evaluating the effect of probiotics on salivary microflora: A clinical controlled trail | |
| AU2011202947A1 (en) | Feline probiotic lactobacilli |